Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;21(3):260-71.
doi: 10.1097/MCP.0000000000000156.

Pneumonia in the neutropenic cancer patient

Affiliations
Review

Pneumonia in the neutropenic cancer patient

Scott E Evans et al. Curr Opin Pulm Med. 2015 May.

Abstract

Purpose of review: Pneumonia is the leading cause of death among neutropenic cancer patients, particularly those with acute leukaemia. Even with empiric therapy, case fatality rates of neutropenic pneumonias remain unacceptably high. However, recent advances in the management of neutropenic pneumonia offer hope for improved outcomes in the cancer setting. This review summarizes recent literature regarding the clinical presentation, microbiologic trends, diagnostic advances and therapeutic recommendations for cancer-related neutropenic pneumonia.

Recent findings: Although neutropenic patients acquire pathogens both in community and nosocomial settings, patients' obligate healthcare exposures result in the frequent identification of multidrug-resistant bacterial organisms on conventional culture-based assessment of respiratory secretions. Modern molecular techniques, including expanded use of galactomannan testing, have further facilitated identification of fungal pathogens, allowing for aggressive interventions that appear to improve patient outcomes. Multiple interested societies have issued updated guidelines for antibiotic therapy of suspected neutropenic pneumonia. The benefit of antibiotic medications may be further enhanced by agents that promote host responses to infection.

Summary: Neutropenic cancer patients have numerous potential causes for pulmonary infiltrates and clinical deterioration, with lower respiratory tract infections among the most deadly. Early clinical suspicion, diagnosis and intervention for neutropenic pneumonia provide cancer patients' best hope for survival.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

DEO has no financial conflicts of interest to disclose.

SEE is an author on US Patent 8,883,174 entitled “Compositions for stimulation of mammalian innate immune responses to pathogens,” and owns stock in Pulmotect, Inc., a company that has licensed technology referenced in this manuscript for clinical development.

Figures

Figure 1
Figure 1
Figure 1a. 50 year old woman with relapsed refractory B-cell lymphoma, neutropenic, with fevers, presenting with consolidation in the lingula. Galactomannan index was 1.98. Figure 1b. 60 year old man with history of Hodgkins lymphoma with autologous bone marrow transplant, 3 years later developed myelodysplastic syndrome with progression to acute myeloid leukemia, presented with neutropenic fevers following. Nodular and ground glass opacities are present bilaterally. BALF was positive for Aspergillus. Figure 1c. 68 year old woman with acute myeloid leukemia with neutropenia after induction chemotherapy. Numerous bilateral pulmonary nodules were seen, most prominent in the RLL superior segment. BALF was positive for aspergillus. Figure 1d. 50 year old woman with acute myeloid leukemia, received induction chemotherapy, had prolonged neutropenia, and developed fevers with bilateral nodular and ground glass opacities. Note the largest nodular density in the right lower lobe has a central low atenuation zone consistent with necrosis. This is seen more easily in the righ thand panel. Figure 1e. 54 year old man who presented with fevers and ground glass opacities to his local physician. After he failed to respond to antibiotics he was admitted to a local hospital and diagnosed with acute myeloid leukemia. He was transferred to receive induction chemotherapy. At the time of presentation patient had bilateral ground glass opacities as shown above, BAL was positive for Aspergillus.
Figure 1
Figure 1
Figure 1a. 50 year old woman with relapsed refractory B-cell lymphoma, neutropenic, with fevers, presenting with consolidation in the lingula. Galactomannan index was 1.98. Figure 1b. 60 year old man with history of Hodgkins lymphoma with autologous bone marrow transplant, 3 years later developed myelodysplastic syndrome with progression to acute myeloid leukemia, presented with neutropenic fevers following. Nodular and ground glass opacities are present bilaterally. BALF was positive for Aspergillus. Figure 1c. 68 year old woman with acute myeloid leukemia with neutropenia after induction chemotherapy. Numerous bilateral pulmonary nodules were seen, most prominent in the RLL superior segment. BALF was positive for aspergillus. Figure 1d. 50 year old woman with acute myeloid leukemia, received induction chemotherapy, had prolonged neutropenia, and developed fevers with bilateral nodular and ground glass opacities. Note the largest nodular density in the right lower lobe has a central low atenuation zone consistent with necrosis. This is seen more easily in the righ thand panel. Figure 1e. 54 year old man who presented with fevers and ground glass opacities to his local physician. After he failed to respond to antibiotics he was admitted to a local hospital and diagnosed with acute myeloid leukemia. He was transferred to receive induction chemotherapy. At the time of presentation patient had bilateral ground glass opacities as shown above, BAL was positive for Aspergillus.
Figure 1
Figure 1
Figure 1a. 50 year old woman with relapsed refractory B-cell lymphoma, neutropenic, with fevers, presenting with consolidation in the lingula. Galactomannan index was 1.98. Figure 1b. 60 year old man with history of Hodgkins lymphoma with autologous bone marrow transplant, 3 years later developed myelodysplastic syndrome with progression to acute myeloid leukemia, presented with neutropenic fevers following. Nodular and ground glass opacities are present bilaterally. BALF was positive for Aspergillus. Figure 1c. 68 year old woman with acute myeloid leukemia with neutropenia after induction chemotherapy. Numerous bilateral pulmonary nodules were seen, most prominent in the RLL superior segment. BALF was positive for aspergillus. Figure 1d. 50 year old woman with acute myeloid leukemia, received induction chemotherapy, had prolonged neutropenia, and developed fevers with bilateral nodular and ground glass opacities. Note the largest nodular density in the right lower lobe has a central low atenuation zone consistent with necrosis. This is seen more easily in the righ thand panel. Figure 1e. 54 year old man who presented with fevers and ground glass opacities to his local physician. After he failed to respond to antibiotics he was admitted to a local hospital and diagnosed with acute myeloid leukemia. He was transferred to receive induction chemotherapy. At the time of presentation patient had bilateral ground glass opacities as shown above, BAL was positive for Aspergillus.
Figure 1
Figure 1
Figure 1a. 50 year old woman with relapsed refractory B-cell lymphoma, neutropenic, with fevers, presenting with consolidation in the lingula. Galactomannan index was 1.98. Figure 1b. 60 year old man with history of Hodgkins lymphoma with autologous bone marrow transplant, 3 years later developed myelodysplastic syndrome with progression to acute myeloid leukemia, presented with neutropenic fevers following. Nodular and ground glass opacities are present bilaterally. BALF was positive for Aspergillus. Figure 1c. 68 year old woman with acute myeloid leukemia with neutropenia after induction chemotherapy. Numerous bilateral pulmonary nodules were seen, most prominent in the RLL superior segment. BALF was positive for aspergillus. Figure 1d. 50 year old woman with acute myeloid leukemia, received induction chemotherapy, had prolonged neutropenia, and developed fevers with bilateral nodular and ground glass opacities. Note the largest nodular density in the right lower lobe has a central low atenuation zone consistent with necrosis. This is seen more easily in the righ thand panel. Figure 1e. 54 year old man who presented with fevers and ground glass opacities to his local physician. After he failed to respond to antibiotics he was admitted to a local hospital and diagnosed with acute myeloid leukemia. He was transferred to receive induction chemotherapy. At the time of presentation patient had bilateral ground glass opacities as shown above, BAL was positive for Aspergillus.
Figure 1
Figure 1
Figure 1a. 50 year old woman with relapsed refractory B-cell lymphoma, neutropenic, with fevers, presenting with consolidation in the lingula. Galactomannan index was 1.98. Figure 1b. 60 year old man with history of Hodgkins lymphoma with autologous bone marrow transplant, 3 years later developed myelodysplastic syndrome with progression to acute myeloid leukemia, presented with neutropenic fevers following. Nodular and ground glass opacities are present bilaterally. BALF was positive for Aspergillus. Figure 1c. 68 year old woman with acute myeloid leukemia with neutropenia after induction chemotherapy. Numerous bilateral pulmonary nodules were seen, most prominent in the RLL superior segment. BALF was positive for aspergillus. Figure 1d. 50 year old woman with acute myeloid leukemia, received induction chemotherapy, had prolonged neutropenia, and developed fevers with bilateral nodular and ground glass opacities. Note the largest nodular density in the right lower lobe has a central low atenuation zone consistent with necrosis. This is seen more easily in the righ thand panel. Figure 1e. 54 year old man who presented with fevers and ground glass opacities to his local physician. After he failed to respond to antibiotics he was admitted to a local hospital and diagnosed with acute myeloid leukemia. He was transferred to receive induction chemotherapy. At the time of presentation patient had bilateral ground glass opacities as shown above, BAL was positive for Aspergillus.
Figure 1
Figure 1
Figure 1a. 50 year old woman with relapsed refractory B-cell lymphoma, neutropenic, with fevers, presenting with consolidation in the lingula. Galactomannan index was 1.98. Figure 1b. 60 year old man with history of Hodgkins lymphoma with autologous bone marrow transplant, 3 years later developed myelodysplastic syndrome with progression to acute myeloid leukemia, presented with neutropenic fevers following. Nodular and ground glass opacities are present bilaterally. BALF was positive for Aspergillus. Figure 1c. 68 year old woman with acute myeloid leukemia with neutropenia after induction chemotherapy. Numerous bilateral pulmonary nodules were seen, most prominent in the RLL superior segment. BALF was positive for aspergillus. Figure 1d. 50 year old woman with acute myeloid leukemia, received induction chemotherapy, had prolonged neutropenia, and developed fevers with bilateral nodular and ground glass opacities. Note the largest nodular density in the right lower lobe has a central low atenuation zone consistent with necrosis. This is seen more easily in the righ thand panel. Figure 1e. 54 year old man who presented with fevers and ground glass opacities to his local physician. After he failed to respond to antibiotics he was admitted to a local hospital and diagnosed with acute myeloid leukemia. He was transferred to receive induction chemotherapy. At the time of presentation patient had bilateral ground glass opacities as shown above, BAL was positive for Aspergillus.

Similar articles

Cited by

References

    1. File TM. Community-acquired pneumonia. Lancet. 2003;362(9400):1991–2001. - PMC - PubMed
    1. Joos L, Tamm M. Breakdown of pulmonary host defense in the immunocompromised host: cancer chemotherapy. Proc Am Thorac Soc. 2005;2(5):445–8. - PubMed
    1. Mizgerd JP. Lung infection--a public health priority. PLoS Med. 2006;3(2):e76. - PMC - PubMed
    1. WHO. The World Health Report 2004 -- Changing History. Geneva: World Health Organization; 2004.
    1. Ahmed S, Siddiqui AK, Rossoff L, Sison CP, Rai KR. Pulmonary complications in chronic lymphocytic leukemia. Cancer. 2003;98(9):1912–7. - PubMed